Australia's most trusted
source of pharma news
Posted 22 January 2025 PM
In a move to deliver "rapid and reliable patient access" to its game-changing nasal spray for the treatment of erectile dysfunction, Brisbane based LTR Pharma has joined forces with Symbion, one of Australia's largest pharmaceutical wholesalers.
The non-exclusive strategic partnership, which commences on 1 March 2025, will facilitate the nationwide distribution of LTR's product Spontan via the early access scheme and sets a new foundation for Spontan's commercial launch once the appropriate regulatory approval process is completed.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.